Zobrazeno 1 - 10
of 61
pro vyhledávání: '"K R, Paterson"'
Publikováno v:
Practical Diabetes. 38:7-12
Autor:
B Miles Fisher, Alan J. Jaap, Naveed Sattar, Joyce McKenzie, K. R. Paterson, Adrian J. Stanley
Publikováno v:
Clinical Endocrinology. 65:40-44
BACKGROUND Increasingly strong links are being recognized between diabetes, insulin resistance and liver fat accumulation [e.g. nonalcoholic fatty liver disease (NAFLD)]. Recent data indicating that hormone replacement therapy (HRT) may lessen diabet
Autor:
JL Robertson, Simeen Akhtar, John R. Petrie, GC Jones, Florence Brown, K. R. Paterson, Colin Perry
Publikováno v:
Practical Diabetes International. 22:207-210
Access to reliable information is an essential component of effective self-care in diabetes. We sought to explore sources of information used by people with diabetes, and their views on the adequacy of this information. We developed an investigator-a
Publikováno v:
The British Journal of Diabetes & Vascular Disease. 2:137-142
Diabetic nephropathy in patients with type 2 diabetes is associated with progressive renal failure and accelerated cardiovascular disease. We performed a retrospective review of 126 patients who presented to a combined diabetic-renal clinic between 1
Autor:
D.W. Motherwell, A Cormack, Kevin A. Deans, K. R. Paterson, B M Fisher, D St J O'Reilly, J Geddes
Publikováno v:
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 44:391-393
Background: Elevated troponin concentrations may be observed in a wide spectrum of medical disorders in people without evidence of overt ischaemic heart disease. The prospective relationship between serum cardiac troponin I (cTnI) and diabetic ketoac
Autor:
D. G. Colin-Jones, M. J. S. Langman, J. Beresford, D. H. Lawson, K. R. Paterson, Richard F A Logan, A. C. Flind, Martin Vessey
Publikováno v:
Pharmacoepidemiology and Drug Safety. 7:319-322
The pattern of mortality after 15 years of observation is reported among almost 10,000 patients who were taking cimetidine when they were first recruited between 1977 and 1980. Many took the drug for a number of years, some switching to other antisec
Publikováno v:
QJM. 90:353-358
Diabetic nephropathy is a major cause of renal failure, accounting for 20% of patients starting dialysis. In clinical trials, effective blood-pressure control, especially by angiotensin-converting-enzyme inhibitors (ACEIs), retards the rate of progre
Autor:
D. E. Grobbee, P. Stonier, D. H. Lawson, H. W. Hense, G. H. de Bock, P. Block, K. R. Paterson, K. Bridgman
Publikováno v:
European Journal of Clinical Pharmacology. 49:73-79
A prospective observational cohort study of the angiotensin inhibitor, ramipril, was undertaken in four countries within the European Community-Netherlands, United Kingdom, Germany and Belgium. A total of 10,377 consecutive patients with essential hy
Publikováno v:
Pharmacoepidemiology & Drug Safety. 2:205-216
Objective — The original study objective was to assess the safety and tolerability of a controlled release formulation of salbutamol (‘Volmax®’), with particular regard to side-effects related to the delivery system. As the study progressed, a
Publikováno v:
Diabetes, obesitymetabolism. 10(7)
Given the long-term health consequences and increasing incidence of type 2 diabetes, there is great interest to potentially prevent or delay its onset. Primary prevention studies have demonstrated that intensive exercise and weight reduction, and to